We propose that both cohesin overexpression and SMC1A mutations accelerate the acquisition of a mutator phenotype driving tumorigenesis by triggering additional genetic changes that allow a growth advantage and CRC development (Fig. 4). This evidence concerns the gene SMC1A and colorectal carcinoma.